• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CSL 0.11% $275.50

CSL LIMITED

Montu is a fully licensed medical cannabis company with a clear focus on the Australian... Montu is a fully licensed medical cannabis company with a clear focus on the Australian and New Zealand market. While the company offers its own medicinal-grade cannabis and cannabis-based medicines under the Circle brand, Montu's primary focus is making it easier for patients to access these crucial treatments.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CSL
European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
03/05/24 0 234
03/05/24 Last post  W534220 Comments Created with Sketch.  0  Views Created with Sketch.  234 
CSL
Real world wveidence CSL cell based flu vaccine more effective than egg based
03/05/24 0 190
03/05/24 Last post  W534220 Comments Created with Sketch.  0  Views Created with Sketch.  190 
CSL 03/05/24 0 237
03/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  237 
CSL
News: CSL CSL Seqirus And ARS Pharma Sign Agreement To Commercialise Neffy In Australia And New...
03/05/24 0 153
03/05/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  153 
CSL 02/05/24 7 3.2K
02/05/24 Last post  Burgerbuns Comments Created with Sketch.  7  Views Created with Sketch.  3.2K 
CSL 02/05/24 51 25K
02/05/24 Last post  W534220 Comments Created with Sketch.  51  Views Created with Sketch.  25K 
CSL
News: CSL ARS Pharmaceuticals CHMP Opinion On Neffy Marketing Authorization Application Expected In...
30/04/24 0 185
30/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  185 
CSL
News: CSL Australian shares rise on banks, IT boost; Fed policy meet on tap
29/04/24 0 206
29/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  206 

See All Discussions arrow Created with Sketch.

Timeline

Notification of cessation of securities - CSL
03 May 12:12
 
Shareholder Information Meetings
23 Apr 09:58
 
CSL Australia Investor Site Tour Presentations
11 Apr 08:25
 
Publication of AEGIS II Trial Data
08 Apr 08:33
 
Notification of cessation of securities - CSL
05 Apr 15:20
 
CSL prices US$1.25 billion in Corporate Bonds
27 Mar 08:31
 
View More arrow Created with Sketch.
(20min delay)
Last
$275.50
Change
-0.300(0.11%)
Mkt cap ! $133.1B
Open High Low Value Volume
$276.76 $277.00 $275.36 $128.2M 465.0K

Buyers (Bids)

No. Vol. Price($)
1 100 $275.30
 

Sellers (Offers)

Price($) Vol. No.
$275.68 189 1
View Market Depth
Last trade - 16.10pm 06/05/2024 (20 minute delay) ?
Last
$275.43
  Change
-0.300 ( 0.30 %)
Open High Low Volume
$276.39 $277.00 $275.39 183080
Last updated 15.59pm 06/05/2024 ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.